South San Francisco, CA – July 1, 2011 – Jonathan Wolfson, co-founder and CEO of Solazyme, Inc (NASDAQ: SZYM), today issued the following statement lauding ASTM International for approving the use of hydrotreated renewable jet fuel in commercial aviation.

“We applaud the historic ruling by ASTM International, and the continued work of both ATA and CAAFI, to implement sustainable initiatives for the aviation industry. Today’s ruling approving the use of algae- and other sustainably-derived biofuels in commercial flight, is a regulatory breakthrough and provides a critical step in the commercialization of advanced, low-carbon biofuels. Solazyme commends these leading industry organizations for their continued commitment to secure alternative energy supplies.”

###

About Solazyme, Inc.

Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care. Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.

Canada’s lead beauty retailers launch breakthrough, miracle ingredient, alguronic acid, throughout the country

South San Francisco – June 30, 2011 –Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, has signed agreements with Sephora Canada andthe leading Canadian multimedia retailer, The Shopping Channel®, to launch Algenist™, Solazyme’s microalgae-based prestige anti-aging skincare line throughout the country. In an unprecedented beauty launch that couples world-class biotechnology with Canada’s most prominent beauty retailers, the Algenist product line will begin selling in all 26 Canadian Sephora stores and on The Shopping Channel’s highest rated beauty programming starting in July 2011.

Algenist is a product line of advanced anti-aging skincare products formulated with Solazyme’s breakthrough ingredient, alguronic acid, an unexpected discovery which was found by the company’s leading biotechnology scientists while researching microalgae for renewable energy solutions. When studied for potential anti-aging benefits, alguronic acid demonstrated significant results and outperformed some of the most well known anti-aging ingredients on the market including hyaluronic acid, retinol and vitamins C and E.

“Algenist comes from a lineage of biotechnology expertise that is not only pioneering the future of skincare, but reinvigorated the luxury skin and personal care space,” said Frederic Stoeckel, Senior Vice President & General Manager, Solazyme Health Sciences. “Sephora and The Shopping Channel provide incredible support and access to some of the largest markets in the world and we look forward to a successful launch with their respective audiences in Canada.”

“At Sephora, we are relentless in our search for exclusive and unique product offerings to redefine the Canadian beauty landscape. Algenist’s pioneering work in producing microalgae ingredients from its biotechnology platform is a brand that is poised to do this,” says Lori Castagna, VP/DMM Merchandising and Marketing, Sephora Canada. “Algenist is an extremely innovative addition to our skincare assortment and we look forward to introducing it to our discerning clients.”

“The Shopping Channel is very excited to be launching the Algenist skin care line in Canada. Our buyers know that Canadian women are some of the most savy and discerning customers in the world, looking for great products, latest technologies and ultimately – results.’ said Lella Liuzzi, Vice-President, Merchandising, The Shopping Channel. ‘We are confident that both our existing customers and those who have yet to discover The Shopping Channel will embrace the Algenist brand . It’s an excellent compliment to our already strong beauty brand assortment”.

In March of 2011, Solazyme successfully launched the initial Algenist product portfolio in more than 850 retail Sephora stores worldwide and on QVC’s lead beauty programming. Algenist ranked immediately after the launch as a top selling brand in both Sephora USA and on QVC.

The line of innovative alguronic acid based products will launch in Canada with three initial product offerings including the Algenist Concentrated Serum, the Algenist Anti-Aging Moisturizer, and the Algenist Complete Eye Renewal Balm. The Algenist Concentrated Serum minimizes the look of wrinkles and boosts skin radiance. The Algenist Anti-Aging Moisturizer nourishes and moisturizes skin, improves firmness, and minimizes the appearance of fine lines and wrinkles, while the Algenist Complete Eye Renewal Balm firms skin while minimizing the appearance of fine lines around the eye area.

###

About Solazyme, Inc.

Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.

Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.

About Sephora Americas:

Since 1998, Sephora has been TRANSFORMING BEAUTY in the U.S. Today, Sephora Americas operates more than 280 stores in the U.S. and Canada as well as the world’s top beauty website, Sephora.com. In 2010 Sephora expanded into Latin America where it partnered with the Brazilian beauty market leader Sacks.com, and plans to open retail stores in Mexico in 2011. Sephora is well known for its unique retail concept, which is rooted in its distinctive open-sell store design, the beauty expertise of its sales consultants and, most importantly, its unparalleled combination of over 200 classic and emerging brands across a broad range of product categories including skincare, color, fragrance, bath & body, smilecare, and haircare, as well as Sephora’s own private label. Sephora has also been recognized as a leading digital brand and continues to advance this arena through mobile and social media initiatives including an active Facebook page, BeautyTalk-its online beauty community, its mobile site and iPhone App. In addition to its North and Latin American business and its initiative with JCPenney, which includes more than 230 Sephora inside JCPenney locations, Sephora today has more than 1,000 stores within 24 countries in Europe and 60 locations in China. Sephora was founded in France in 1970 and acquired in 1997 by Paris-based LVMH Moët Hennessy Louis Vuitton, the world’s leading luxury products group. For further information, please visit www.sephora.com

About The Shopping Channel:

The Shopping Channel, Canada’s only nationally televised shopping service, is an industry leading diversified retailer and distributor. Since the launch of The Shopping Channel’s initial television channel in 1987, it has become a true award winning multi-channel retailer through its leading online presence at www.theShoppingChannel.com; and now celebrates 11th year of eCommerce retail activity. With 600+ dedicated employees focused on delivering a world class Customer Experience, The Shopping Channel is recognized as Canada’s premier success story in electronic and diversified retailing. The Shopping Channel is a division of Rogers Broadcasting Limited (a subsidiary of Rogers Media Inc).

Company Recognized as a Top Industry Leader in Sustainable Fuels and Chemicals

South San Francisco, CA – June 21, 2011 – Solazyme, Inc.(NASDAQ: SZYM), a renewable oil and bioproducts company, received the San Francisco Business Times Cleantech and Sustainability Award in the Fuels, Chemicals and Specialty Products category. The awards recognize top industry leaders in green business, cleantech, energy conservation and alternative energy.

Solazyme was chosen as the Fuels, Chemicals and Specialty Products winner based on criteria including innovative technology, proven commercial success and positive environmental impact. In the process of selecting winners, the San Francisco Business Times evaluated nearly 200 companies in 15 categories.

“We are honored to be recognized by the San Francisco Business Times,” said Solazyme co-founder and President Harrison Dillon. “Solazyme is committed to creating renewable tailored oils in a scalable, reliable, and cost effective manner to help reduce our dependence on petroleum and other oils that are economically and environmentally unsustainable.”

Solazyme is commercializing in the fuels and chemicals, nutrition and health sciences market areas. In 2010,Solazyme delivered more than 20,000 gallons of SoladieselHRF-76® renewable marine diesel and Solajet™HRJ-5, 100% algae derived jet fuel, to the US Navy, marking the world’s largest delivery of 100% microbially-derived, non-alcohol, advanced biofuel. Also in 2010, Solazyme launched the Golden Chlorella in nutraceutical and dietary supplement products which is in products for sale at Whole Foods, GNC and other retailers. In March 2011, Solazyme celebrated the global launch of the Algenist anti-aging skincare line in over 800 Sephora stores and on QVC’s lead beauty programming.

The U.S. Military also recently demonstrated Solazyme’s 100% algal-derived jet fuel, Solajet™HRJ-5, in an MH-60S Seahawk helicopter test flight, marking the first military aircraft to fly on an algal-based jet fuel.

###

About Solazyme, Inc.

Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care. Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.

Applauds ASTM International historic preliminary approval of algae based biofuels for aviation

South San Francisco, CA – June 20, 2011 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today that the US Navy successfully demonstrated Solazyme’s 100% algal-derived jet fuel, SolajetHRJ-5®, in an MH-60S Seahawk helicopter test flight in a 50/50 blend with petroleum-derived jet fuel. This marks the first military aircraft to fly on an algal-based jet fuel in history. This test flight preceded the historic announcement by ASTM International that it has preliminarily approved biofuel from algae and other renewable sources to be blended with traditional jet fuel on commercial flights worldwide, with formal approval expected sometime in July.

“We applaud ASTM International and the ATA and CAAFI for their efforts to advance the world’s newest and most sustainable fuels for aviation. The aviation industry has demonstrated a strong leadership position in fuel supply diversification and sustainability, and today’s announcement is a major step in its efforts to commercialize advanced low-carbon biofuels,” said Jonathan Wolfson, CEO, Solazyme.

“Solazyme is honored to be working with the US Navy and DLA-Energy in driving forward the testing and certification process for advanced biofuels. The successful flight demonstration of the Seahawk helicopter on a 50/50 blend of SolajetHRJ-5® and petroleum-derived jet fuel marks a significant milestone in this process, and reinforces the Navy’s commitment to securing our nation’s energy supply.”

Honeywell UOP was the refining partner on the jet fuel delivery, and has been working with Solazyme since 2009 on multiple contracts with the US military.

To date, Solazyme is the only company to provide the US Navy with microbially-derived advanced aviation and marine fuel. These advanced biofuels are drop-in replacements to petroleum-based fuel, requiring no modification to engines or military logistics infrastructure. The fuels also meet Section 526 of the Energy Independence and Security Act of 2007.

For more information on the MH 60S Seahawk helicopter fuel and a Riverine Command Boat demonstrations on Solazyme’s SoladieselHRF-76® fuel, please see the videos below:

The U.S. Navy Successfully Demonstrates SolajetHRJ-5® fuel

The U.S. Navy Successfully Demonstrates SoladieselHRF-76® fuel

###

About Solazyme, Inc.

Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value tailored oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care. Solazyme’s oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure. For more information, please visit our website: http://www.solazyme.com

Solazyme®, the Solazyme logo and other trademarks or service names are the trademarks of Solazyme, Inc.

Morgan brings more than 20 years of experience in commercializing food ingredients to the game changing microalgae foods venture

June 8, 2011 – SOUTH SAN FRANCISCO, Calif. — Solazyme Roquette Nutritionals, a microalgae-derived food ingredients company, has expanded its management team by naming Jodie Morgan as President and General Manager. Morgan brings over 20 years of experience in commercializing chemicals and food ingredients, including her most recent role as President of SPI Foods, a global specialty food ingredients manufacturer purchased by Corn Products in 2007.

“Jodie’s vast experience in the ingredients industry will dramatically accelerate Solazyme Roquette Nutritionals’ market development and commercialization of this new class of natural, healthy and functional microalgae food ingredients,” said Jonathan Wolfson, CEO, Solazyme and Solazyme Roquette Nutritionals.

“Jodie brings a unique set of skills to this role. Her experiences running manufacturing and M&A integration, coupled with her broad background in sales and marketing, make her an ideal leader.”

While at SPI Foods, Morgan was instrumental in reorganizing and repositioning the business, including negotiating long-term supply agreements and successfully executing global and product line expansions.

“Solazyme Roquette Nutritionals’ innovative technology represents an incredible opportunity to introduce entirely new ingredients that allow food manufactures to create healthy products without taste, texture and functionality compromise. Alternatives are simply not available today,” said Morgan.

“I’m excited to couple my experience integrating companies in both the ingredients space, and beyond, with this incredible technology platform to expedite the market entry of new microalgae based food ingredients.” Morgan holds a degree in mechanical engineering from the University of Delaware and an M.B.A from the West Chester University.

About Solazyme Roquette Nutritionals LLC

Solazyme Roquette Nutritionals LLC (SRNutritionals) offers an entirely new category of natural, healthy and multifunctional ingredients based on microalgae that help consumers live healthier lives. These ingredients offer superior nutritionals properties along with outstanding taste and texture. Founded in 2010 and headquartered in South San Francisco, Solazyme Roquette Nutritionals’ portfolio includes a variety of oil, protein and fiber based products aimed at delivering better tasting foods with a vastly superior health profile compared to ingredients in the market today.

SOUTH SAN FRANCISCO, Calif. — Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced the closing of its initial public offering of 12,621,250 shares of common stock at $18.00 per share. The closing includes the exercise in full of the underwriters’ overallotment option on the first day of trading, bringing total gross proceeds raised to $227.2 million. The offering included 600,000 shares sold by selling stockholders.

Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. acted as joint book-running managers for the offering. Jefferies & Company, Inc. acted as lead manager, and Pacific Crest Securities LLC and Lazard Capital Markets LLC acted as co-managers.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities, in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

A copy of the prospectus relating to the offering may be obtained by contacting Morgan Stanley & Co. Incorporated, Attn: Prospectus Department, 180 Varick Street, New York, NY 10014; or Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com.

About Solazyme, Inc.

Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value tailored oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care. Solazyme’s oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure. For more information, please visit our website: http://www.solazyme.com

Solazyme®, the Solazyme logo and other trademarks or service names are the trademarks of Solazyme, Inc.

SOUTH SAN FRANCISCO, Calif. — Solazyme, Inc., a renewable oil and bioproducts company, today announced the pricing of its initial public offering of 10,975,000 shares of common stock at a price to the public of $18.00 per share. Of the shares of common stock in the offering, Solazyme is offering 10,375,000 shares, and selling stockholders are offering 600,000 shares. In addition, Solazyme has granted the underwriters a 30-day option to purchase up to an additional 1,646,250 shares of common stock, solely to cover over-allotments, if any. Solazyme will not receive any proceeds from the sale of shares by the selling stockholders.

Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. are acting as joint book-running managers for the offering. Jefferies & Company, Inc. is acting as lead manager, and Pacific Crest Securities LLC and Lazard Capital Markets LLC are acting as co-managers. The shares will begin trading on the NASDAQ Global Select Market on May 27, 2011 under the ticker symbol “SZYM.”

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on May 26, 2011. Any offer or sale will be made solely by means of a written prospectus forming part of the effective registration statement. Copies of the final prospectus relating to the offering may be obtained from: Morgan Stanley & Co. Incorporated,

Attn: Prospectus Department, 180 Varick Street, New York, NY 10014; or Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Solazyme, Inc.

Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.

Solazyme®, the Solazyme logo and other trademarks or service names are the trademarks of Solazyme, Inc.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6740390&lang=en

South San Francisco, CA – May 6, 2011 – Solazyme, Inc., a leading renewable oils and bioproducts company, today announced a two-year joint development agreement (JDA) with Bunge Limited (NYSE: BG) to develop microbe-derived oils utilizing Brazilian sugar cane feedstock. The agreement builds on Bunge’s earlier equity investment in Solazyme, and the letter of intent signed by both firms in December 2010 that contemplates a manufacturing joint venture for the production of tailored oils at Bunge’s sugar cane mills in Brazil.

Under the terms of the agreement, Solazyme will leverage its algal fermentation technology in combination with Bunge’s oil processing and milling capabilities to cost-effectively produce targeted triglyceride oils. Development will take place at Bunge’s facility in Moema, Brazil, and at Solazyme’s laboratories in South San Francisco and Campinas, Brazil.

To further align the incentives of both parties, the two companies also entered into a Warrant Agreement. This agreement issues a warrant to Bunge for shares of Solazyme that vests upon the successful completion of key milestones, ultimately targeting the construction of a commercial facility with 100,000 metric tons of output oil coming online in 2013.

About Solazyme:
Solazyme, Inc. is a renewable oil and bioproducts company and a leader in industrial biotechnology. Founded in 2003 and headquartered in South San Francisco, Solazyme’s technology allows microbes to produce oil and biomaterials in standard fermentation facilities quickly, efficiently and at large scale. These oils and biomaterials are tailored not only for biofuel production, but also as replacements for fossil petroleum, plant oils and animal fats in a diverse range of products running from clean fuels and chemicals to cosmetics and foods. Solazyme’s oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure. Solazyme’s investors among others include Braemar Energy Ventures, Harris & Harris Group, Lightspeed VenturePartners, The Roda Group, VantagePoint Venture Partners, and Zygote Ventures. For more information, please visit our website: http://www.solazyme.com

About Bunge Limited:
Bunge Limited (www.bunge.com, NYSE: BG) is a leading global agribusiness and food company with approximately 32,000 employees in more than 30 countries. Bunge buys, sells, stores and transports oilseeds and grains to serve customers worldwide; processes oilseeds to make protein meal for animal feed and edible oil products for commercial customers and consumers; produces sugar and ethanol from sugarcane; mills wheat and corn to make ingredients used by food companies; and sells fertilizer in North and South America. Founded in 1818, the company is headquartered in White Plains, New York.

South San Francisco, CA – May 3, 2011 – Solazyme, a renewable oil company and leader in industrial biotechnology, announced today that the company has expanded its board of directors with the addition of Ian Clark, current CEO of Genentech, and Ann Mather, former Chief Financial Officer of Pixar Studios, and current board member at companies including Google, Netflix and MGM Holdings, Inc..

Solazyme Chief Executive Officer and Co-founder, Jonathan Wolfson, commented: “Both Ian and Ann bring strong leadership and valuable business experience to the board at Solazyme. We are excited to welcome their insight to our board as we continue to grow and mature.”

Ian Clark
Ian Clark is Chief Executive Officer, Genentech, a member of the Roche Group and head of North American Commercial Operations. He joined Genentech in 2003 as senior vice president and general manager, BioOncology and, in January 2006, was named executive vice president, Commercial Operations and became a member of the Executive Committee. Prior to joining Genentech, Mr. Clark served as president of Novartis Canada, overseeing all of the company’s country operations. His previous board experience includes Vernalis and Dendreon both publicly traded biopharmaceutical companies. Mr. Clark is also on the Board of the BIO Industry Association and an Advisor to the Institute of Life Sciences at Southampton University in the UK.

Ann Mather
Ann Mather is lead director at MGM Holdings Inc., a motion picture and television production and distribution company. She is also a member of the board at Google, where she serves as chair of the Audit Committee, and is a director at Netflix, Glu Mobile Inc., and MoneyGram International. Ms. Mather was formerly Chief Financial Officer at Pixar Studios and prior to that held senior roles at the Walt Disney Company.

March 11, 2011 – SOUTH SAN FRANCISCO, Calif. — Solazyme, Inc., a renewable oil company and leader in industrial biotechnology, announced today the company has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC) for a proposed initial public offering. Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. will act as joint book-running managers for the offering with Pacific Crest Securities and Lazard Capital Markets as co-managers. The number of shares to be sold in the proposed offering and the offering price have not yet been determined.

A copy of the prospectus relating to these securities may be obtained, when available, from: Morgan Stanley & Co. Incorporated, Prospectus Department, 1585 Broadway, New York, NY 10036 or Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any State in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State.

About Solazyme:

Solazyme, Inc. is a renewable oil company and a leader in industrial biotechnology. Founded in 2003 and headquartered in South San Francisco, Solazyme’s proprietary technology transforms a range of low-cost plant-based sugars into high-value oils. Our renewable products can replace or enhance oils derived from the world’s three existing sources—petroleum, plant and animal fats. We tailor the composition of our oils to address specific customer requirements, offering superior performance characteristics at a competitive cost to conventional oils. Solazyme’s oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure. Solazyme’s investors, among others, include Braemar Energy Ventures, Harris & Harris Group, Lightspeed VenturePartners, The Roda Group, VantagePoint Venture Partners, and Zygote Ventures.